Table 1.
Distribution of demographic, clinical characteristics according to SOFA score categories.
| All 3233 (100%) | Category 1 (0–1 points) 1356 (41.9%) | Category 2 (2–3 points) 1370 (42.4%) | Category 3 (4–5 points) 402 (12.4%) | Category 4 (> 5 points) 105 (3.2%) | P Value | |
|---|---|---|---|---|---|---|
| Age | 75.15 ± 11.89 | 74 ± 12 | 76.32 ± 11.5 | 74.7 ± 12.36 | 74 ± 11.52 | < 0.001 |
| Female Gender | 1544 (47.8%) | 766 (56.5%) | 602 (43.9%) | 140 (34.8%) | 36 (34.3%) | < 0.001 |
| IHD | 1794 (55.5%) | 686 (50.6%) | 808 (59.0%) | 237 (59.0%) | 63 (60.0%) | < 0.001 |
| DM | 1735 (53.7%) | 733 (54.1%) | 738 (53.9%) | 219 (54.5%) | 45 (42.9%) | .161 |
| Hypertension | 2696 (83.4%) | 1150 (84.8%) | 1148 (83.8%) | 324 (80.6%) | 74 (70.5%) | < 0.001 |
| CKD | 886 (27.4%) | 216 (15.9%) | 465 (33.9%) | 164 (40.8%) | 41 (39.0%) | < 0.001 |
| COPD | 492 (15.2%) | 201 (14.8%) | 209 (15.3%) | 68 (16.9%) | 14 (13.3%) | .717 |
| Normal EF (50–70%) | 1086 (33.6%) | 481 (35.5%) | 474 (34.6%) | 107 (26.6%) | 24 (22.9%) | 0.001 |
| Mild EF (40–50%) | 293 (9.1%) | 126 (9.3%) | 120 (8.8%) | 43 (10.7%) | 4 (3.8%) | 0.001 |
| Moderate EF (30–40%) | 345 (10.7%) | 162 (11.9%) | 135 (9.9%) | 37 (9.2%) | 11 (10.5%) | 0.001 |
| Severely Reduced EF (< 30%) | 500 (15.5%) | 202 (14.9%) | 203 (14.8%) | 73 (18.2%) | 22 (21.0%) | 0.001 |
| Missing Echocardiography | 1009 (31.2%) | 385 (28.4%) | 438 (32.0%) | 142 (35.3%) | 44 (41.9%) | 0.001 |
| GFR | 51.1 ± 7.4 | 65 ± 26 | 43 ± 22.5 | 35.8 ± 25.4 | 33.6 ± 3.6 | < 0.001 |
| Creatinine | 1.57 ± 1 | 1 ± 0.29 | 1.7 ± 0.71 | 2.61 ± 1.75 | 2.86 ± 2 | < 0.001 |
| BUN | 32 ± 18.64 | 22.59 ± 9.13 | 35.69 ± 17 | 47.81 ± 23.9 | 53 ± 30.5 | < 0.001 |
| Hemoglobin | 11.6 ± 2 | 11.9 ± 1.9 | 11.4 ± 2 | 11.24 ± 2 | 11.7 ± 2.3 | < 0.001 |
| Platelets | 299 ± 90 | 254 ± 85 | 380 ± 90 | 201 ± 103 | 205 ± 100 | < 0.001 |
| SOFA | 2 ± 1.5 | 0.69 ± 0.46 | 2.38 ± 0.48 | 4.35 ± 0.47 | 6.5 ± 0.78 | < 0.001 |
| Beta Blockers** | 2031 (62.8%) | 872 (64.3%) | 860 (62.8%) | 241 (60.0%) | 58 (55.2%) | 0.15 |
| ACE Inhibitors** | 1535 (47.5%) | 704 (51.9%) | 628 (45.8%) | 154 (38.3%) | 49 (46.7%) | < 0.001 |
| K sparing** | 507 (15.7%) | 190 (14.0%) | 217 (15.8%) | 76 (18.9%) | 24 (22.9%) | 0.017 |
| Diuretics** | 1980 (61.2%) | 703 (51.8%) | 923 (67.4%) | 281 (69.9%) | 73 (69.5%) | < 0.001 |
| Length of stay (days) | 8.08 ± 8.9 | 6.32 ± 6.45 | 8.46 ± 9.47 | 10.77 ± 10.41 | 15.54 ± 14.97 | < 0.001 |
**Drugs at admission.